Answers are grounded in this paper and cite their sources.
The CIN phenotype is a predictive marker for survival and may be used to select high-risk patients with stages II and III CRC.
No takes yet. Share an insight, caveat, or question.
Watanabe et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: